Article

Whole Genome Sequence Analysis and Homology Modelling of a 3C Like Peptidase and a Non-Structural Protein 3 of the SARS-CoV-2 Shows Protein Ligand Interaction with an Aza-Peptide and a Noncovalent Lead Inhibitor with Possible Antiviral Properties

2020-04-26

Abstract excerpt

The family of viruses belonging to Coronaviridae mainly consist of virulent pathogens that have a zoonotic property, Severe Acute Respiratory Syndrome (SARS-CoV) and Middle East Respiratory Syndrome (MERS-CoV) of this family have emerged before and now the SARS-CoV-2 has emerged in China. Characterization of spike glycoproteins, polyproteins and other viral proteins from viruses are important for vaccine dev...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 75d425b0-b28b-582e-a807-0f531f880231
DOI: 10.26434/chemrxiv.11846943.v9

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Whole Genome Sequence Analysis and Homology Modelling of a 3C Like Peptidase and a Non-Structural Protein 3 of the SARS-CoV-2 Shows Protein Ligand Interaction with an Aza-Peptide and a Noncovalent Lead Inhibitor with Possible Antiviral PropertiesDOI 10.26434/chemrxiv.11846943.v9Read

Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19Semantic proximity Read

SARS-CoV-2: Origin, Evolution, and Targeting InhibitionSemantic proximity Read

Antiviral Peptides as Promising Therapeutics against SARS-CoV-2Semantic proximity Read

Compilation of Potential Protein Targets for SARS-CoV-2: Preparation of Homology Model and Active Site Determination for Future Rational Antiviral DesignSemantic proximity Read

Minireview of progress in the structural study of SARS-CoV-2 proteinsSemantic proximity Read

Structural Insights Into the Design of Peptide-based Drug or Diagnostic Reagent Antagonizing SARS-COV-2Semantic proximity Read

Genomics functional analysis and drug screening of SARS-CoV-2Semantic proximity Read

Structural Differences In 3C-like protease (Mpro) From SARS-CoV and SARS-CoV-2: Molecular Insights For Drug Repurposing Against COVID-19 Revealed by Molecular Dynamics SimulationsSemantic proximity Read

Compatibility of the Ligand Binding Sites in the Spike Glycoprotein of COVID-19 with those in the Aminopeptidase and the Caveolins 1, 2 ProteinsSemantic proximity Read

Anti-viral chimeric protein RetroMAD1™ potently block SARS-CoV-2 viral entry and propagationSemantic proximity Read

Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteasesSemantic proximity Read

Molecular Basis of SARS-CoV‑2 Infection and Rational Design of Potential Antiviral Agents: Modeling and Simulation ApproachesSemantic proximity Read